Chair

Chair

Olena I Klindukhova, MD

Medical College of Wisconsin

Muscle Loss With Weight Loss Is Modulated by Age, Sex, and Protein Intake and May Affect Glucose Homeostasis in Adults With Obesity

Melanie S. Haines, MD

Massachusetts General Hospital / Harvard Medical School

Tirzepatide as a Promising Treatment for Metabolic Hypogonadism in Obese Men: Effects on Metabolic and Hormonal Parameters

Rossella Cannarella, MD, PhD

University of Catania

A novel Melanocortin and Gut-peptide Multiple Agonist for Obesity and Diabetes Treatment

Christian Ludwig Roth, MD

Seattle Children's Rsrch Institute

Chair

Maja Stefanovic-Racic, MD,PhD

University of Pittsburgh

The Effect of GLP-1 Administration on Food Intake in People With Weight Loss Failure Post-metabolic Surgery.

Kleopatra Alexiadou, MD, PhD, MRCP (UK)

IMPERIAL COLLEGE LONDON

One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women with and without Hormone Therapy

Regina Castaneda, M.D.

Mayo Clinic

Going Backwards as a Means of Moving Forward: Severe Hypoglycemia after Bariatric Surgery

Hye Jeong Han, D.O

University of Rochester

Perioperative Weight Loss With GLP-1 Receptor Agonists in Patients Receiving Bariatric Surgery

Angela Rao, MD

Stanford Health Care

Dynamic Proteomic Profiling in a 5-week Crossover Trial of Liraglutide in Obesity Reveals Weight-Dependent Myostatin Downregulation and Multi-Pathway Effects Beyond Weight Reduction

Konstantinos Stefanakis, MD

Harvard Medical School